![Roger Adsett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Adsett
Operationeel Directeur bij
INSMED INCORPORATED
Vermogen: 11 M $ op 31-05-2026
Profiel
Roger Adsett is currently Director at Definium Therapeutics, Inc. since 2026 and Chief Operating Officer at Insmed, Inc. since 2019.
Former roles include Independent Director at Landos Biopharma, Inc. from 2022 to 2024, SVP, Head-Gastrointestinal & Internal Medicine at Shire Plc from 2015 to 2016, Director-Marketing & Brand at AstraZeneca PLC from 1994 to 2005, and Marketing Director positions at AstraZeneca R & D Lund and Nexium, Inc. Education includes an undergraduate degree from Bucknell University and an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INSMED INCORPORATED 0,05% | 03-06-2026 | 98.603 ( 0,05% ) | 11 M $ | 31-05-2026 |
| 29-01-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Roger Adsett
| Bedrijven | Functie | Begin |
|---|---|---|
| INSMED INCORPORATED | Operationeel Directeur | 14-11-2019 |
| DEFINIUM THERAPEUTICS, INC. | Directeur/Bestuurslid | 29-01-2026 |
Eerdere bekende functies van Roger Adsett
| Bedrijven | Functie | Einde |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur/Bestuurslid | 23-05-2024 |
| SHIRE | Corporate Officer/Principal | 01-09-2016 |
| ASTRAZENECA PLC | Verkoop & Marketing | 01-10-2005 |
Nexium, Inc.
 Nexium, Inc. Investment ManagersFinance Functions as a pension/retirement fund | Verkoop & Marketing | - |
AstraZeneca R & D Lund | Verkoop & Marketing | - |
Opleiding van Roger Adsett
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
75
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca R & D Lund | |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexium, Inc.
Nexium, Inc. Investment ManagersFinance Functions as a pension/retirement fund | Finance |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Mind Medicine (MindMed), Inc.
 Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
